Peanut

IgGenix announced the first patient dosed with IGNX001, a monoclonal antibody-based therapeutic for peanut allergy.

The FDA has approved Palforzia, an oral immunotherapy designed to protect children aged 1 to 3 years with peanut allergies from reactions caused by accidental exposure, according to a press release.

Families of children with peanut allergies that pursued oral immunotherapy cited remission and the potential for disease modification as their reason, according to a study published in The Journal of Allergy and Immunology: In Practice.

The 2017 Addendum Guidelines for the Prevention of Peanut Allergy were associated with lower new-onset anaphylaxis rates in children, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Consuming peanut products from infancy through age 5 years provided lasting tolerance into adolescence without the need to regularly upkeep consumption, according to a study published in NEJM Evidence.

After a woman developed a rash on her face and fingers several times, her doctors discovered the cause was her cell phone, specifically the acrylate screen protector on her cell phone.

Cases of food protein-induced enterocolitis syndrome induced by peanuts increased at a pediatric allergy practice between 2015 and 2023, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Healio compiled the most-read news in allergy, asthma and immunology posted in June.

In a cohort of Japanese men and women, higher peanut consumption decreased risk for total and ischemic stroke, as well as CVD, but not ischemic heart disease, according to results of the Japan Public Health Center study.

HOUSTON — Food allergies affect 6% to 8% of children and 2% to 3% of adults, according to a presentation at the American College of Asthma, Allergy & Immunology Scientific Meeting.